KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) Return on Sales (2016 - 2026)

Staar Surgical (STAA) has disclosed Return on Sales for 16 consecutive years, with 0.38% as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Return on Sales rose 25.0% year-over-year to 0.38%, compared with a TTM value of 0.4% through Jan 2026, down 34.0%, and an annual FY2026 reading of 0.37%, down 32.0% over the prior year.
  • Return on Sales was 0.38% for Q1 2026 at Staar Surgical, down from 0.1% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.79% in Q4 2023 and bottomed at 1.27% in Q1 2025.
  • Average Return on Sales over 5 years is 0.07%, with a median of 0.07% recorded in 2023.
  • The sharpest move saw Return on Sales plummeted -7961bps in 2022, then soared 74bps in 2023.
  • Year by year, Return on Sales stood at 0.05% in 2022, then skyrocketed by 1393bps to 0.79% in 2023, then tumbled by -179bps to 0.63% in 2024, then surged by 116bps to 0.1% in 2025, then tumbled by -481bps to 0.38% in 2026.
  • Business Quant data shows Return on Sales for STAA at 0.38% in Q1 2026, 0.1% in Q3 2025, and 0.65% in Q2 2025.